Lasa Supergenerics Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

50.10

40.67

40.67

40.67

22.86

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

68.18

107.96

118.24

100.79

82.43

Loan funds

Secured loans

-

-

-

34.48

39.03

Unsecured loans

-

-

-

-

29.70

Total

118.29

148.63

158.92

175.95

174.02

Uses of funds

Fixed assets

Gross block

225.50

216.81

225.34

219.54

211.87

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

106.54

94.72

82.38

67.35

50.17

Net block

118.96

122.09

142.95

152.19

161.69

Capital work-in-progress

4.64

4.58

-

-

7.21

Investments

0.39

-

-

-

-

Net current assets

Current assets, loans & advances

39.86

72.54

64.91

79.80

89.59

Less : current liabilities & provisions

45.57

50.57

48.94

56.04

84.47

Total net current assets

-5.70

21.97

15.97

23.76

5.12

Miscellaneous expenses not written

-

-

-

-

-

Total

118.29

148.63

158.92

175.95

174.02

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

501.01

406.73

406.73

406.73

228.64